<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04307524</url>
  </required_header>
  <id_info>
    <org_study_id>cesarean scar niche</org_study_id>
    <nct_id>NCT04307524</nct_id>
  </id_info>
  <brief_title>Laparoscopic Repair of Cesarean Scar Niche</brief_title>
  <official_title>Laparoscopic Repair Of Cesarean Scar Niche: Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zagazig University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zagazig University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of laparoscopy repair of cesarean scar niche in resolution of symptoms related to
      niche as compared to expectant management.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recently, The percentage of Cesarean section (CS) deliveries has dramatically increased in
      most countries. The presence of a niche at the site of a CS scar has been observed. A niche
      is mainly a sonographic finding defined as a triangular anechoic area at site of incision. (
      Mascarello et al, 2017) Alternative terms for a niche are Cesarean scar defect (Wang et al,
      2009), deficient Cesarean scar (Ofili-Yebovi et al, 2008), diverticulum (Surapaneni et al,
      2008), pouch (Fabres el al, 2003) and isthmocele. (bogres el al, 2010) As not all women with
      previous CS develop a niche, it is a matter of interest to identify the risk factors that may
      predict their development. (Sholapurkar , 2018) Possible causes of this condition may be
      surgery or patient related. Surgery related factors as low cervical incision, incomplete
      closure of the uterus (decidual sparing) and inadequate hemostasis. Patient related factors
      may be attributed to infection. ( Vervoort et al, 2015) Cesarean scar niche may be
      asymptomatic or may cause a number of obstetrical and gynecological problems (cesarean scar
      syndrome) . ( Vervoort et al,2015b) Obstetrical complications of the niche are cesarean scar
      ectopic pregnancy, placenta previa and morbidly adherent placenta, cesarean scar dehiscence
      following incomplete abortion secondary to uterotonic drugs, Scar dehiscence and tender scar
      even scar rupture (Tanimura el al, 2015) Gynecological symptoms of the niche are
      postmenstrual spotting, Intermenstrual bleeding, Dysmenorrheal, Dysparunia and secondary
      infertility. (Tanimura el al, 2015) Various methods to detect and measure a niche have been
      described. The majority of papers have evaluated the niche with the use of transvaginal
      sonography (TVS) (Vaate et al, 2011), and contrast‚Äêenhanced sonohysterography (SHG) (Bij de
      Vaate et al, 2011), but a minority have used hysteroscopy (El-Mazny et al, 2011) or
      hysterosalpingography. (Surapaneni and Silberzweig, 2008 ) At present there is no consensus
      regarding the gold standard for the detection and measurement of a niche. (Vaate et al, 2014)
      Symptomatic cesarean scar niche (cesarean scar syndrome) can be managed conservatively using
      combined oral contraceptive pills especially in women not seeking fertility, or it can be
      treated using minimal invasive surgery as hysteroscopic resection (vervoot et al,2017) ,
      laparoscopic repair (ma et al,2017) or vaginal repair (Yao, 2014) In this study we will
      evaluate laparoscopic management of cesarean scar niche
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 15, 2020</start_date>
  <completion_date type="Anticipated">March 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 15, 2021</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>computer-generated sequence</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>post-menstrual spotting</measure>
    <time_frame>6 month after intervention</time_frame>
    <description>number of days of post-menstrual spotting &quot;spotting or bleeding after 8 days of menstruation whatever the amount</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>menstrual related pain</measure>
    <time_frame>6 month after intervention</time_frame>
    <description>degree of menstrual related pain as descriped by the patient on Visual Analogue Scale of pain from 1 to 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>infertility</measure>
    <time_frame>6 month after intervention</time_frame>
    <description>failure of conception despite regular sexual intercourse within 6 months from intervention or stopping gynera</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cesarean Section Complications</condition>
  <arm_group>
    <arm_group_label>laparoscopic repair</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>suture repair of cesarean scar niche using laparoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>medical treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conservative management</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic repair</intervention_name>
    <description>laparoscopic suture repair of cesarean scar niche</description>
    <arm_group_label>laparoscopic repair</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>medical treatment in the form of combined hormonal contraception</intervention_name>
    <description>patient will receive for three months daily without interruption, no pill-free interval drug names is &quot;Genera&quot; BAYERhealthcare</description>
    <arm_group_label>medical treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. History of cesarean section.

          2. Postmenstrual and/or intermenstrual spotting.

          3. Cesarean scar niche of at least 2 mm in depth diagnosed by saline infusion sonography

        Exclusion Criteria:

          1. pregnancy

          2. Uterine anomalies

          3. Hysterotomy.

          4. history Placenta previa and MAP

          5. Upper segment incision, Vertical uterine incision

          6. submucosal fibroids

          7. adenomyosis.

          8. History atypical endometrial cells, cervical dysplasia,

          9. cervical or pelvic infection.

         10. Irregular cycle.

         11. lactation amenorrhea.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 21, 2020</study_first_submitted>
  <study_first_submitted_qc>March 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2020</study_first_posted>
  <last_update_submitted>March 11, 2020</last_update_submitted>
  <last_update_submitted_qc>March 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zagazig University</investigator_affiliation>
    <investigator_full_name>Mahmoud Ismail Abdel Rahman Kotb</investigator_full_name>
    <investigator_title>Specialist &amp; Assistant Lecturer of obstetrics and gynecology</investigator_title>
  </responsible_party>
  <keyword>cesarean scar niche</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

